Literature DB >> 22264658

Delay between the initial symptoms, the diagnosis and the onset of specific treatment in elderly patients with lung cancer.

Etienne Giroux Leprieur1, Sylvie Labrune, Violaine Giraud, Thierry Gendry, Daniel Cobarzan, Thierry Chinet.   

Abstract

INTRODUCTION: The proportion of elderly patients with lung cancer is increasing. The objectives of this study were to describe the initial symptoms in elderly patients (≥ 70 years) with lung cancer and to describe the diagnostic and treatment delays. PATIENTS AND METHODS: We reviewed all consecutive patients with lung cancer that were diagnosed between 2006 and 2008 in our department. The initial symptoms and delays in the diagnosis and treatment in elderly patients were compared with those of younger patients.
RESULTS: One hundred ninety-three patients were included (26 small-cell cancers and 167 non-small-cell lung cancers [NSCLCs]). Ninety-two patients (47.7%) were ≥ 70 years old. No statistical differences were identified between the 2 groups concerning initial symptoms. In elderly patients, the delay between the initial symptoms and the first visit with a thoracic oncologist (median 1.6 months [IQR 23 days-3.3 months]), the delay between the first visit and the specific treatment (median 1.1 months [IQR 18 days-1.8 months]), and the delay between initial symptoms and the specific treatment (median 3 months [IQR 2-5.7 months]) were similar to those in the younger patients (P = .101, P = .084, and P = .671, respectively). Eighty-four percent of the elderly patients were actively treated vs. 98% of the younger patients (P = .001).
CONCLUSION: We identified no differences regarding the initial symptoms in elderly patients with lung cancer compared with those in younger patients. The delays in diagnosis and treatment were similar between the 2 groups.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22264658     DOI: 10.1016/j.cllc.2011.11.010

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN: 1525-7304            Impact factor:   4.785


  10 in total

1.  Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer.

Authors:  Pamela Samson; Aalok Patel; Tasha Garrett; Traves Crabtree; Daniel Kreisel; A Sasha Krupnick; G Alexander Patterson; Stephen Broderick; Bryan F Meyers; Varun Puri
Journal:  Ann Thorac Surg       Date:  2015-04-16       Impact factor: 4.330

2.  Pathways to a lung cancer diagnosis.

Authors:  Lisa Carter-Harris; Carla Penrod Hermann; Claire Burke Draucker
Journal:  J Am Assoc Nurse Pract       Date:  2015-03-12       Impact factor: 1.165

3.  Functional status in older patients with lung cancer: an observational cohort study.

Authors:  Anne-Laure Couderc; Pascale Tomasini; Laurent Greillier; Emilie Nouguerède; Dominique Rey; Coline Montegut; Pascal-Alexandre Thomas; Fabrice Barlesi; Patrick Villani
Journal:  Support Care Cancer       Date:  2022-01-15       Impact factor: 3.359

4.  Predictivity of the comorbidity indices for geriatric syndromes.

Authors:  Kubra Canaslan; Esra Ates Bulut; Suleyman Emre Kocyigit; Ali Ekrem Aydin; Ahmet Turan Isik
Journal:  BMC Geriatr       Date:  2022-05-19       Impact factor: 4.070

5.  Assessment of baseline symptom burden in treatment-naïve patients with lung cancer: an observational study.

Authors:  Tito R Mendoza; Kenneth L Kehl; Oluwatosin Bamidele; Loretta A Williams; Qiuling Shi; Charles S Cleeland; George Simon
Journal:  Support Care Cancer       Date:  2019-01-19       Impact factor: 3.603

6.  Transfer between hospitals as a predictor of delay in diagnosis and treatment of patients with Non-Small Cell Lung Cancer - a register based cohort-study.

Authors:  Maria Iachina; Erik Jakobsen; Anne Kudsk Fallesen; Anders Green
Journal:  BMC Health Serv Res       Date:  2017-04-12       Impact factor: 2.655

Review 7.  Targeted Therapy for Older Patients with Non-Small Cell Lung Cancer: Systematic Review and Guidelines from the French Society of Geriatric Oncology (SoFOG) and the French-Language Society of Pulmonology (SPLF)/French-Language Oncology Group (GOLF).

Authors:  Laurent Greillier; Manon Gauvrit; Elena Paillaud; Nicolas Girard; Coline Montégut; Rabia Boulahssass; Marie Wislez; Frédéric Pamoukdjian; Romain Corre; Mathilde Cabart; Philippe Caillet; Yaniss Belaroussi; Matthieu Frasca; Pernelle Noize; Pascal Wang; Soraya Mebarki; Simone Mathoulin-Pelissier; Anne-Laure Couderc
Journal:  Cancers (Basel)       Date:  2022-02-02       Impact factor: 6.639

8.  Prognostic factors and patients' profile in treated stage I and II lung adenocarcinoma: a Hospital's Cancer Registry-based analysis.

Authors:  Fernando Conrado Abrão; Stela Verzinhasse Peres; Igor Renato Louro Bruno de Abreu; Riad Naim Younes
Journal:  J Thorac Dis       Date:  2021-11       Impact factor: 2.895

9.  Experiences of cancer survivors in Europe: Has anything changed? Can artificial intelligence offer a solution?

Authors:  Iman Hesso; Reem Kayyali; Andreas Charalambous; Maria Lavdaniti; Evangelia Stalika; Maria Lelegianni; Shereen Nabhani-Gebara
Journal:  Front Oncol       Date:  2022-09-14       Impact factor: 5.738

10.  Variation in promptness of presentation among 10,297 patients subsequently diagnosed with one of 18 cancers: evidence from a National Audit of Cancer Diagnosis in Primary Care.

Authors:  Stuart Keeble; Gary A Abel; Catherine L Saunders; Sean McPhail; Fiona M Walter; Richard D Neal; Gregory P Rubin; Georgios Lyratzopoulos
Journal:  Int J Cancer       Date:  2014-02-25       Impact factor: 7.396

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.